Eat Just is out to make a major change in the way the world produces and eats meat. The most recent milestone in its mission is the historic regulatory approval it received in Singapore for cultured meat.

"This way of making meat is far and away safer," Josh Tetrick, co-founder and CEO of Eat Just, told Cheddar Monday. "It’s cleaner, and eventually it’s going to be more cost-effective."

Eat Just creates its cultured chicken — which Tetrick calls "no-kill meat" — using animal cells. Tetrick explained those cells can come from a biopsy or cell bank. The company identifies the nutrients needed to feed the cell, and then manufactures it in a bioreactor. 

The new regulatory approval lets Eat Just sell its cultured chicken in Singapore as an ingredient in chicken bites.

But Eat Just has ambitions to eventually get into millions of restaurants. Tetrick said there’s no need to have both conventional and plant-based chicken options on the menu, just a cultured chicken option.

"It satisfies everyone," Tetrick said. "It satisfies people who are trying to eat [no meat] because they don’t want to take a life. It satisfies people who don’t want to contribute to exacerbating climate change. And it satisfies people who just like good old tasty fried chicken and don’t care about any of that stuff. That’s how we think we’re going to really change the food system."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More